Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Australia
(14/week)
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Guatemala
(0/week)
View all
(14/week)
News
United States
(593/week)
Manufacturing
(401/week)
Energy
(303/week)
Technology
(414/week)
Environment
(248/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
Tetracycline antibiotics
Jun 18, 2020
Almirall Announces FDA Approval Of Updated Label For Seysara® (Sarecycline) Tablets
May 29, 2020
Menlo Therapeutics Receives FDA Approval of ZILXI(TM) (minocycline) topical foam, 1.5%, the First Topical Minocycline Treatment for Rosacea
Feb 18, 2020
Foamix Announces Integrated Efficacy Results from the FMX103 1.5% Topical Minocycline Foam Phase 3 Program for Rosacea
Feb 06, 2020
Foamix Announces Publication of Phase 3 Studies Evaluating FMX103 for the Treatment of Papulopustular Rosacea in Journal of the American Academy of Dermatology
Jan 14, 2020
Foamix Announces AMZEEQ(TM) (minocycline) Achievement of Preferred Status on Express Scripts National Preferred Formulary, One of the Largest Commercial Formularies in the U.S.
Jan 09, 2020
Foamix Announces AMZEEQ(TM) (minocycline) Topical Foam Available in Pharmacies Nationwide on January 13th for the Treatment of Moderate to Severe Acne
Nov 04, 2019
Foamix Announces Publication of AMZEEQ(TM) (minocycline) Topical Foam Long Term Safety Data for Treatment Up to 1 Year in Journal of Clinical and Aesthetic Dermatology
Oct 18, 2019
Foamix Receives FDA Approval of AMZEEQ(TM) Topical Minocycline Treatment for Millions of Moderate to Severe Acne Sufferers
Jun 19, 2019
Global Acne Market Spotlight 2017-2018 & 2019-2026 - ResearchAndMarkets.com
May 22, 2019
BioPharmX Announces Last Patient Visit in Phase 2b Trial of BPX-04 for Papulopustular Rosacea
Mar 04, 2019
BioPharmX Completes Enrollment in Phase 2b Trial of BPX-04 for Patients with Papulopustular Rosacea
Jan 17, 2019
Novel Oral Antibiotic Treatment Seysara(TM) (sarecycline) Now Available
Nov 26, 2018
Antibiotics: Global Markets to 2023
Jul 31, 2018
BioPharmX Receives IRB Approval to Initiate Phase 2 Trial of BPX-04 for the Treatment of Rosacea
Mar 20, 2018
U.S. Patent and Trademark Office Awards BioPharmX Patent Protection for Novel Tetracycline-class Topical Drug Compositions
Feb 01, 2018
Neogen releases easiest dairy antibiotic tests
Jan 12, 2018
BioPharmX To Present BPX-04 Rosacea Data At Two Leading Clinical Conferences This Month
Dec 20, 2017
FDA Accepts New Drug Application For Seysara(TM) (Sarecycline) For The Treatment Of Moderate To Severe Acne
Dec 13, 2017
Hovione Announces Enrollment of First Patient in MARS, a Phase 2 Clinical Trial for the Treatment of Moderate to Severe Inflammatory Rosacea with its Proprietary Minocycline Topical Gel
Dec 12, 2017
Novasep Signs Manufacturing Agreement with Clinical-stage Biopharmaceutical Company Tetraphase for Eravacycline API
Page 1
››
Latest News
Apr 24, 2024
Suzano Ventures invests up to US$5 million into Bioform Technologies to further develop bio-based plastic...
Apr 24, 2024
Woodside Energy Group Ltd Annual General Meeting Address by Chair Richard Goyder and CEO Meg O'Neill
Apr 24, 2024
RTX breaks ground on $115 million expansion of Alabama missile integration facility
Apr 24, 2024
GA-ASI Mojave Lights Up the Yuma Desert in Live-Fire Demonstration
Apr 24, 2024
AV unveils new AI capability and autonomy kit for unmanned systems
Apr 24, 2024
Rocket Lab Successfully Deploys Satellites ~500km Apart to Separate Orbits For KAIST and NASA
Apr 24, 2024
Sturm, Ruger & Company, Inc. to Report First Quarter 2024 Financial Results on Tuesday, May 7
Apr 24, 2024
Encore Wire Reports First Quarter Results
View all News
Agenda
17
June
France
Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024, 17 - 21 June 2024, Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024 There can be no sustainable world without peace and security. Founded in 1967, the exhibition...
21
May
Paris Marriott Rive Gauche & Conference Center
Future Artillery, 21-23 May 2024, Paris Marriott Rive Gauche & Conference Center, France
DELIVERING FIRES IN THE MULTI-DOMAIN BATTLESPACE As artillery reasserts itself as the ‘King of Battlefield’ in the wake...
21
May
United Arab Emirates
ADNEC (Abu Dhabi National Exhibition Centre), Abu Dhabi, Al Khaleej Al Arabi St - Al Rawdah - Al Ma'arid - Abu Dhabi, UAE
ISNR Abu Dhabi 2024, 21-23 May 2024, ADNEC (Abu Dhabi National Exhibition Centre), Abu Dhabi, Al Khaleej Al Arabi St - Al Rawdah - Al Ma'arid - Abu Dhabi, UAE
ISNR ACCELERATING TRANSFORMATION IN THE NATIONAL SECURITY ECOSYSTEM ISNR Abu Dhabi is the region’s most trusted...
View All Events